The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

about

Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication.

P2860

Q52619009-B5887E75-A363-4ECD-B7A4-0E8A5463932E

P2860

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

Item

http://www.wikidata.org/entity/Q47569409

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@en

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@nl

type

Item

label

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@en

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@nl

prefLabel

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@en

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

@nl

P1476

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure

@en

P2093

Jonathan Z Li

http://www.w3.org/2001/XMLSchema#string

José Ramón Arribas

http://www.w3.org/2001/XMLSchema#string

Roger Paredes

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance

Contribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapy

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo.

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy.

P304

S847-S850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1093/INFDIS/JIX430

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

suppl_9

http://www.w3.org/2001/XMLSchema#string

P478

216

http://www.w3.org/2001/XMLSchema#string

P50

Natalia Stella-Ascariz

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207001

http://www.w3.org/2001/XMLSchema#string

P932

5853963

http://www.w3.org/2001/XMLSchema#string

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

about

P2860

P2860

The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932